Veteran owned small business Spartan Medical Inc revealed on Wednesday that it plans to introduce Altapure LLC's AP-4 High-level Disinfection-System (HLDS) across the US market in the fight against COVID-19.
This critically needed, AP-4 advanced-ultrasonic-technology ensures that all healthcare and long-term care facilities, schools, universities, cruise lines, among others, can provide the cleanest/safest environment to fellow Americans. Altapure's first fully integrated high-level disinfection system AP–4 Medical HLD System will eliminate all bacteria, spores and viruses in a treated space. The system is easily operated by one person and many facilities have one person running two to three machines at a time.
The AP–4 is a single mobile unit platform, containing a combined submicron aerosol output device and environmental air re-processor system with data feedback. The process's agent is organic, biodegradable, food safe and leaves zero residue. Its PAA agent is an EPA registered cold sterilant, bactericide, fungicide, virucide and sporicide. In short, there has not yet been a pathogen that can survive the disinfection cycle, making the implementation of this state-of-the-art solution paramount during COVID-19 and beyond.
In collaboration with NASA, Altapure has shown efficacy in the sterilization of PPE with the 'peracetic acid technology.
Novocure announces presentation of new TTFields research at EANO and ESMO 2025 meetings
OSR Holdings to acquire Korean non-invasive glucose monitor developer Woori IO
Autonomix Medical secures new US patent to expand precision nerve-targeted therapies
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux
Implantica receives positive FDA feedback on final RefluxStop PMA submission
Tempus secures FDA clearance for RNA-based xR IVD diagnostic device
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem
GSK commits USD30bn to US R&D and manufacturing expansion
ArtPlayer Promotes Elderly Wellbeing with Digital Signage and Streaming Art in Finnish Care Homes
Implantica produces 10,000 RefluxStop units ahead of planned US launch